• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身吞噬的自我抑制:“自身标志物”CD47 对 SIRPα 的亲和力决定了抑制的效力,但仅在低表达水平下如此。

Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels.

机构信息

Biophysical Engineering Lab, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Blood Cells Mol Dis. 2010 Jun 15;45(1):67-74. doi: 10.1016/j.bcmd.2010.02.016. Epub 2010 Mar 17.

DOI:10.1016/j.bcmd.2010.02.016
PMID:20299253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2878922/
Abstract

Phagocytes engulf foreign cells but not 'self' in part because self cells express CD47 as a ligand for signal regulatory protein SIRPalpha, which inhibits phagocytosis. Motivated by reports of upregulation of CD47 on both normal and cancerous stem cells [1: Jaiswal et al., 2009] and also by polymorphisms in SIRPalpha [2: Takenaka et al., 2007], we show here that inhibition of engulfment correlates with affinity of CD47 for SIRPalpha - but only at low levels of CD47. One common human polymorph of SIRPalpha is studied and binds more strongly to human-CD47 than to mouse-CD47 (K(d) approximately 0.12 microM and 6.9 microM, respectively) and does not bind sheep red blood cells (RBCs) - which are well-established targets of human macrophages; in comparison, a common mouse polymorph of SIRPalpha binds with similar affinity to human and mouse CD47 (K(d) approximately 0.22 microM). Using immunoglobulin (IgG)-opsonized particles with varying levels of either human- or mouse-CD47, the effective inhibition constants K(i) for blocking phagocytosis are then determined with both human- and mouse-derived macrophages. Only human phagocytes show significant differences in man versus mouse K(i)'s and only at CD47 levels below normal densities for RBCs. While phospho-signaling through human-SIRPalpha shows similar trends, consistent again with the affinity differences, saturating levels of CD47 (>K(i)) can signal and inhibit phagocytosis regardless of man versus mouse. Quantitative analyses here prompt more complete characterizations of both CD47 levels and SIRPalpha polymorphisms when attempting to study in vivo effects of these key proteins in innate immunity.

摘要

吞噬细胞吞噬外来细胞,但不会吞噬“自身”细胞,部分原因是自身细胞表达 CD47 作为信号调节蛋白 SIRPα的配体,从而抑制吞噬作用。受正常和癌细胞干细胞中 CD47 上调的报道[1:Jaiswal 等人,2009]以及 SIRPα多态性的报道[2:Takenaka 等人,2007]的启发,我们在这里表明,吞噬作用的抑制与 CD47 与 SIRPα的亲和力相关-但仅在 CD47 低水平时相关。研究了 SIRPα的一种常见人类多态性,它与人-CD47 的结合比与鼠-CD47 的结合更强(Kd 分别约为 0.12µM 和 6.9µM),并且不结合绵羊红细胞(RBC)-这是人类巨噬细胞的既定靶标;相比之下,常见的鼠 SIRPα多态性与人 CD47 和鼠 CD47 的结合具有相似的亲和力(Kd 约为 0.22µM)。使用具有不同水平人源或鼠源 CD47 的免疫球蛋白(IgG)包被颗粒,然后用源自人源和鼠源的巨噬细胞来确定阻断吞噬作用的有效抑制常数 K i。只有人源吞噬细胞在人与鼠 K i之间存在显著差异,并且仅在 CD47 水平低于 RBC 的正常密度时才存在差异。虽然通过人源 SIRPα的磷酸化信号显示出相似的趋势,这再次与亲和力差异一致,但无论人源还是鼠源,只要 CD47 水平超过(K i),就可以发出信号并抑制吞噬作用。这里的定量分析提示,在试图研究这些先天免疫关键蛋白在体内的作用时,需要更全面地描述 CD47 水平和 SIRPα多态性。

相似文献

1
Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels.自身吞噬的自我抑制:“自身标志物”CD47 对 SIRPα 的亲和力决定了抑制的效力,但仅在低表达水平下如此。
Blood Cells Mol Dis. 2010 Jun 15;45(1):67-74. doi: 10.1016/j.bcmd.2010.02.016. Epub 2010 Mar 17.
2
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.靶向髓系检查点受体 SIRPα 可增强先天和适应性免疫反应,从而促进抗肿瘤活性。
J Hematol Oncol. 2020 Nov 30;13(1):160. doi: 10.1186/s13045-020-00989-w.
3
Macrophages show higher levels of engulfment after disruption of interactions between CD47 and the checkpoint receptor SIRPα.巨噬细胞在破坏 CD47 与检查点受体 SIRPα 之间的相互作用后,吞噬作用水平升高。
J Cell Sci. 2020 Mar 6;133(5):jcs237800. doi: 10.1242/jcs.237800.
4
Selection and Characterization of FD164, a High-Affinity Signal Regulatory Protein Variant with Balanced Safety and Effectiveness, from a Targeted Epitope Mammalian Cell-Displayed Antibody Library.从靶向表位的哺乳动物细胞展示抗体文库中选择和鉴定具有平衡安全性和有效性的高亲和力信号调节蛋白变体 FD164。
Mol Pharmacol. 2021 Sep;100(3):193-202. doi: 10.1124/molpharm.120.000202. Epub 2021 Jul 27.
5
CD47 functions as a molecular switch for erythrocyte phagocytosis.CD47 作为红细胞吞噬作用的分子开关。
Blood. 2012 Jun 7;119(23):5512-21. doi: 10.1182/blood-2011-10-386805. Epub 2012 Mar 16.
6
"Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.作为信号调节蛋白α(SIRPα)拮抗剂的高亲和力CD47胞外域的“维可牢”工程,可增强抗体依赖性细胞吞噬作用。
J Biol Chem. 2015 May 15;290(20):12650-63. doi: 10.1074/jbc.M115.648220. Epub 2015 Apr 2.
7
Cancer immunotherapy targeting the CD47/SIRPα axis.靶向CD47/SIRPα轴的癌症免疫疗法。
Eur J Cancer. 2017 May;76:100-109. doi: 10.1016/j.ejca.2017.02.013. Epub 2017 Mar 10.
8
Innate immune checkpoint SIRPα/CD47 blockade ameliorates silica-induced pulmonary fibrosis by modulating macrophage immunity.先天性免疫检查点信号调节蛋白α/CD47阻断通过调节巨噬细胞免疫改善二氧化硅诱导的肺纤维化。
Int Immunopharmacol. 2025 May 27;156:114723. doi: 10.1016/j.intimp.2025.114723. Epub 2025 Apr 24.
9
Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody.用 Fc 功能下调的抗 CD47 治疗性抗体调节 CD47-SIRPα 固有免疫检查点轴。
Cancer Immunol Immunother. 2022 Feb;71(2):473-489. doi: 10.1007/s00262-021-03010-6. Epub 2021 Jul 10.
10
Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPα (signal regulatory protein-α) on phagocytes.髓鞘通过髓鞘上的 CD47 与吞噬细胞上的 SIRPα(信号调节蛋白-α)之间的相互作用,下调小胶质细胞和巨噬细胞对髓鞘的吞噬作用。
J Neuroinflammation. 2011 Mar 15;8:24. doi: 10.1186/1742-2094-8-24.

引用本文的文献

1
Cancer Cell Membrane-Wrapped Nanoparticles for Photothermal Therapy and Photoacoustic Imaging of Triple-Negative Breast Cancer.用于三阴性乳腺癌光热治疗和光声成像的癌细胞膜包裹纳米颗粒
ACS Appl Nano Mater. 2025 Aug 15;8(35):17311-17328. doi: 10.1021/acsanm.5c03543. eCollection 2025 Sep 5.
2
Targeting TNFAIP2 with NIR-II CRISPR-Cas9 nanosystem to overcome cisplatin resistance in laryngeal cancer.使用近红外二区CRISPR-Cas9纳米系统靶向TNFAIP2以克服喉癌中的顺铂耐药性。
NPJ Precis Oncol. 2025 Jul 29;9(1):263. doi: 10.1038/s41698-025-01054-w.
3
Nature-Inspired Nanostructures from Multiple-Species Biomembranes: Rational Engineering and Therapeutic Applications in Tumor-Targeted Nanomedicine.

本文引用的文献

1
Conformational changes and signaling in cell and matrix physics.细胞和基质物理学中的构象变化和信号转导。
Curr Biol. 2009 Sep 15;19(17):R781-9. doi: 10.1016/j.cub.2009.06.054.
2
CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.CD47在循环造血干细胞和白血病细胞上上调,以避免被吞噬。
Cell. 2009 Jul 23;138(2):271-85. doi: 10.1016/j.cell.2009.05.046.
3
Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47.通过单独的信号调节蛋白结构以及与CD47复合的结构所解释的配对受体特异性。
源自多物种生物膜的仿生纳米结构:肿瘤靶向纳米医学中的理性工程与治疗应用
Adv Sci (Weinh). 2025 Sep;12(33):e07952. doi: 10.1002/advs.202507952. Epub 2025 Jul 2.
4
Stealth missiles with precision guidance: A novel multifunctional nano-drug delivery system based on biomimetic cell membrane coating technology.具有精确制导的隐形导弹:一种基于仿生细胞膜包衣技术的新型多功能纳米药物递送系统。
Mater Today Bio. 2025 May 30;33:101922. doi: 10.1016/j.mtbio.2025.101922. eCollection 2025 Aug.
5
Precision-Guided Stealth Missiles in Biomedicine: Biological Carrier-Mediated Nanomedicine Hitchhiking Strategy.生物医学中的精确制导隐形导弹:生物载体介导的纳米药物搭便车策略。
Adv Sci (Weinh). 2025 Jun;12(21):e2504672. doi: 10.1002/advs.202504672. Epub 2025 May 8.
6
"Live" Nanomaterials Process Biomimetic Recognition and Assembly In Vivo.“活性”纳米材料在体内进行仿生识别与组装。
Small Sci. 2023 Oct 10;3(11):2300032. doi: 10.1002/smsc.202300032. eCollection 2023 Nov.
7
Super-resolution microscopy unveils the nanoscale organization and self-limiting clustering of CD47 in human erythrocytes.超分辨率显微镜揭示了人类红细胞中CD47的纳米级组织和自我限制聚集。
J Mol Cell Biol. 2025 Mar 21;16(9). doi: 10.1093/jmcb/mjae041.
8
Surface nanocoating of bacteria as a versatile platform to develop living therapeutics.细菌表面纳米涂层作为一种通用平台,用于开发活体治疗药物。
Nat Protoc. 2024 Nov;19(11):3162-3190. doi: 10.1038/s41596-024-01019-6. Epub 2024 Jul 23.
9
Cell membrane-coated nanomaterials for cancer therapy.用于癌症治疗的细胞膜包覆纳米材料。
Mater Today Bio. 2023 Apr 12;20:100633. doi: 10.1016/j.mtbio.2023.100633. eCollection 2023 Jun.
10
Cooperative phagocytosis of solid tumours by macrophages triggers durable anti-tumour responses.巨噬细胞对实体瘤的协同吞噬作用可引发持久的抗肿瘤反应。
Nat Biomed Eng. 2023 Sep;7(9):1081-1096. doi: 10.1038/s41551-023-01031-3. Epub 2023 Apr 24.
Mol Cell. 2008 Jul 25;31(2):266-77. doi: 10.1016/j.molcel.2008.05.026.
4
Innate immune 'self' recognition: a role for CD47-SIRPalpha interactions in hematopoietic stem cell transplantation.固有免疫“自我”识别:CD47-SIRPα相互作用在造血干细胞移植中的作用
Trends Immunol. 2008 May;29(5):203-6. doi: 10.1016/j.it.2008.02.004. Epub 2008 Apr 3.
5
Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells.通过在人类细胞之间的吞噬突触处使肌球蛋白-II失活来抑制“自身”吞噬。
J Cell Biol. 2008 Mar 10;180(5):989-1003. doi: 10.1083/jcb.200708043.
6
Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells.信号调节蛋白α(Sirpa)的多态性调控人类造血干细胞的植入。
Nat Immunol. 2007 Dec;8(12):1313-23. doi: 10.1038/ni1527. Epub 2007 Nov 4.
7
Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production.配对免疫球蛋白样受体与细菌结合并塑造Toll样受体介导的细胞因子产生。
J Immunol. 2007 Apr 1;178(7):4250-9. doi: 10.4049/jimmunol.178.7.4250.
8
Phylogenetic divergence of CD47 interactions with human signal regulatory protein alpha reveals locus of species specificity. Implications for the binding site.CD47与人类信号调节蛋白α相互作用的系统发育差异揭示了物种特异性位点。对结合位点的影响。
J Biol Chem. 2007 Jan 19;282(3):1805-18. doi: 10.1074/jbc.M603923200. Epub 2006 Nov 10.
9
Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47.信号调节蛋白α免疫球蛋白可变区(SIRPα IgV)结构域上的功能元件介导细胞表面与CD47的结合。
J Mol Biol. 2007 Jan 19;365(3):680-93. doi: 10.1016/j.jmb.2006.09.079. Epub 2006 Oct 3.
10
The SIRP family of receptors and immune regulation.信号调节蛋白受体家族与免疫调节
Nat Rev Immunol. 2006 Jun;6(6):457-64. doi: 10.1038/nri1859.